Form 4: Zoetis Inc. Director Michael B. McCallister Acquires Restricted Stock Units

Director Michael B. McCallister acquired 1,596 restricted stock units (RSUs) of Zoetis Inc. on February 19, 2025, which will vest on the first anniversary of the grant date.

Summary

• On February 19, 2025, Michael B. McCallister, a director of Zoetis Inc., was granted 1,596 restricted stock units (RSUs).
• These RSUs were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
• Each RSU represents the contingent right to receive one share of Zoetis Inc. common stock.
• The RSUs will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2025, contingent upon continued service.
• The transaction was reported on February 20, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices, aligning management interests with shareholders.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Future Outlook

The director's holdings will increase upon vesting of the RSUs, aligning their interests with the long-term performance of Zoetis Inc.

Industry Context

This type of equity compensation is common in the pharmaceutical industry to incentivize and retain key personnel.

Stakeholder Impact

• The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Key Dates